Compléter C4 ; humain

Code: 204886-250UG D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

≥60% of the C4 activity present in freshly drawn normal human serum on a mg to mg basis

General description

Native,...


 En savoir plus

Votre prix
$651.56 EACH

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

≥60% of the C4 activity present in freshly drawn normal human serum on a mg to mg basis

General description

Native, human C4 complement component. Glycoprotein composed of three non-identical subunits of M.W. of 93 kDa (α), 75 kDa (β), and 32 kDa (γ) linked by disulfide bonds. Present in normal human serum at 400 µg/ml. On activation of complement via the classical pathway, the C1s subcomponent of the C1 complex is converted to an active serine protease that cleaves the C4 α-chain at peptide bond 77, resulting in production of C4a (M.W. 8740) and C4b fragments (M.W. 193 kDa). The released C4a peptide is one of the three complement-derived anaphylatoxins. The nascent C4b fragment can form a covalent ester bond with target surfaces. This covalent attachment of C4b to target acceptors is required for continuation of activation via classical pathway.

Native, human C4 complement component. Glycoprotein composed of three non-identical subunits of M.W. 93,000 (α), 75,000 (β), and 32,000 (γ) linked by disulfide bonds. Present in normal human serum at 400 µg/ml. On activation of complement via the classical pathway, the C1s subcomponent of the C1 complex is converted to an active serine protease that cleaves the C4 α-chain at peptide bond 77, resulting in the production of C4a (M.W. 8740) and C4b fragments (M.W. 193,000). The released C4a peptide is one of the three complement-derived anaphylatoxins. The nascent C4b fragment can form a covalent ester bond with target surfaces. This covalent attachment of C4b to target acceptors is required for continuation of activation via classical pathway.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Janatova, J. 1983. Ann. N.Y. Acad. Sci. 421, 218.Hammer, C.H., et al. 1981. J. Biol. Chem. 256, 3995.

Packaging

250 µg in Plastic ampoule

Please refer to vial label for lot-specific concentration.

Warning

Toxicity: Standard Handling (A)

assay≥90% (SDS-PAGE)
formliquid
manufacturer/tradenameCalbiochem®
Quality Level100
shipped indry ice
specific activity>3X105 C4H50 units/mg protein
storage conditionavoid repeated freeze/thaw cycles, OK to freeze
storage temp.−70°C
Cas Number80295-48-3
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :



HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.